Continuing Trending of Monkeypox and Covid
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Author: TAG
Webmaster and Administrator of The Acheson Group website.
Southern Hemisphere Flu Season Bodes Ill for U.S.
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19
TAG Expands Assessments to Include Current Communicable Disease Data
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings
The “Why” Behind Day 6 and Multiple COVID Testing
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for
Positive COVID Trends Enable Focus on other Emerging Disease
Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes
Monkeypox Takes Headlines as COVID Turns a Corner
Key Points: In today’s Recommendation for Industry, we discuss the ongoing monkeypox headlines. Read more below. US COVID cases show hints of decline. The 7-day
Indicators Point to CDC Reductions in COVID Control Guidelines
Key Points: In today’s Recommendation for Industry, we discuss CDC’s reduction in COVID guidelines. Read more below. New York Times reports updates about COVID: Hospitalizations
Is There a Risk of Monkeypox Workplace Transmission?
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces
COVID becoming an endemic virus
Key Points: In today’s Recommendation for Industry, we discuss COVID becoming an endemic virus. Read more below. COVID hot spots shift; studies add evidence for
COVID Vaccines Continue to Evolve
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
